Best Small Cap Stocks To Invest In Right Now


This article is in response to Mr. Brian Grosso’s article entitled “Dividend Growth Investors, Wake up!” In it, Mr. Grosso generalized that many if not most dividend growth investors ignore valuation and focus too heavily on large cap stocks. I also got the sense that Mr. Grosso does not comprehend the dividend growth investing strategy. He himself stated that he has warmed up to dividends. I get the impression this is much like someone warming up with their morning cup of coffee. I do not think he has drunk enough coffee yet to wake up and comprehend the actual purpose dividends play in dividend growth investing. It may have something to do with the impression I got while reading his article that, although it was not written, he is growth or total return oriented and enjoys receiving dividends if his investments provide one. He acknowledges their importance but fails to recognize why they are the basis of dividend growth investing. Finally, Mr. Grosso encourages dividend growth investors to move towards small cap stocks that pay dividends and offers investors a few “new” ideas. I am going to take the opportunity to expound on some of the written and unwritten points offered by Mr. Grosso.

Best Small Cap Stocks To Invest In Right Now: ChannelAdvisor Corporation(ECOM )


Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Best Small Cap Stocks To Invest In Right Now: Fiserv, Inc.(FISV)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week:Corcept Therapeutics Inc. (NASDAQ: CORT), Customers Bancorp Inc. (NYSE: CUBI), Ellie Mae Inc. (NYSE: ELLI), Fiserv Inc. (NASDAQ: FISV) and Ulta Beauty Inc. (NASDAQ: ULTA).

Best Small Cap Stocks To Invest In Right Now: Keryx Biopharmaceuticals, Inc.(KERX)


Advisors’ Opinion:

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

  • [By Lisa Levin]

    Keryx Biopharmaceuticals (NASDAQ: KERX) shares shot up 14 percent to $5.17 after the company announced positive top-line results from its pivotal Phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.

  • [By Keith Speights]

    There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week’s Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you’ll want to know about.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Lisa Levin]

    Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

Leave a Reply

Your email address will not be published. Required fields are marked *